These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23978397)

  • 1. Concomitant, sequential, and hybrid therapy for Helicobacter pylori: which one is the correct answer?
    Chitsaz E
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):e125-6. PubMed ID: 23978397
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential therapy for Helicobacter pylori: time to consider making the switch?
    Vakil N; Vaira D
    JAMA; 2008 Sep; 300(11):1346-7. PubMed ID: 18799448
    [No Abstract]   [Full Text] [Related]  

  • 3. Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial.
    Chen KY; Lin TJ; Lin CL; Lee HC; Wang CK; Wu DC
    World J Gastroenterol; 2015 Sep; 21(36):10435-42. PubMed ID: 26420970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori: tailored therapy with novel sequential quadruple therapies.
    Graham DY; Gisbert JP
    Nat Rev Gastroenterol Hepatol; 2013 Jan; 10(1):6-8. PubMed ID: 23183788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary: Helicobacter pylori eradication in Western Australia.
    Tehami NA; Nwokolo CU
    Aliment Pharmacol Ther; 2013 Jan; 37(1):158; discussion 159. PubMed ID: 23205478
    [No Abstract]   [Full Text] [Related]  

  • 6. Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
    Zullo A; Scaccianoce G; De Francesco V; Ruggiero V; D'Ambrosio P; Castorani L; Bonfrate L; Vannella L; Hassan C; Portincasa P
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):647-50. PubMed ID: 23747131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: curing Helicobacter pylori infection in a clinical setting.
    Tursi A
    Aliment Pharmacol Ther; 2013 Apr; 37(7):757-8. PubMed ID: 23458537
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: curing Helicobacter pylori infection in a clinical setting--authors' reply.
    Thirriot F; Tay CY; Marshall BJ
    Aliment Pharmacol Ther; 2013 Apr; 37(7):758-9. PubMed ID: 23458538
    [No Abstract]   [Full Text] [Related]  

  • 9. Hybrid, sequential and concomitant therapies for Helicobacter pylori eradication: A systematic review and meta-analysis.
    Song ZQ; Zhou LY
    World J Gastroenterol; 2016 May; 22(19):4766-75. PubMed ID: 27217708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: something new to consider in the treatment of Helicobacter pylori infection?
    Howden CW
    Aliment Pharmacol Ther; 2012 Aug; 36(4):399. PubMed ID: 22803645
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.
    Hwang JJ; Lee DH; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Sep; 21(35):10234-41. PubMed ID: 26401089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Helicobacter pylori in Latin America.
    Slater CM; Ford AC
    Lancet; 2012 Feb; 379(9814):407; author reply 408-9. PubMed ID: 22305216
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Helicobacter pylori in Latin America.
    Gatta L; Vakil N; Vaira D
    Lancet; 2012 Feb; 379(9814):407-8; author reply 408-9. PubMed ID: 22305217
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Helicobacter pylori in Latin America.
    Graham DY; Trespalacios AA
    Lancet; 2012 Feb; 379(9814):408; author reply 408-9. PubMed ID: 22305218
    [No Abstract]   [Full Text] [Related]  

  • 15. Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study.
    Apostolopoulos P; Koumoutsos I; Ekmektzoglou K; Dogantzis P; Vlachou E; Kalantzis C; Tsibouris P; Alexandrakis G
    Scand J Gastroenterol; 2016; 51(2):145-51. PubMed ID: 26435055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential therapy--more studies are still required.
    Merali A; Leontiadis GI
    Aliment Pharmacol Ther; 2012 Jan; 35(1):194-5; discussion 195-6. PubMed ID: 22150536
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary: something new to consider in the treatment of Helicobacter pylori infection? Authors' reply.
    Nseir W; Mograbi J; Abu-Elheja O
    Aliment Pharmacol Ther; 2012 Aug; 36(4):399-400. PubMed ID: 22803646
    [No Abstract]   [Full Text] [Related]  

  • 18. Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients.
    Abuhammour A; Dajani A; Nounou M; Zakaria M
    Arab J Gastroenterol; 2016 Sep; 17(3):131-136. PubMed ID: 27665525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: the ethics of using inferior regimens in H. pylori randomised trials.
    Graham DY; Fischbach LA
    Aliment Pharmacol Ther; 2012 Apr; 35(7):852-4; discussion 858. PubMed ID: 22404411
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
    Georgopoulos SD; Xirouchakis E; Martinez-Gonzales B; Zampeli E; Grivas E; Spiliadi C; Sotiropoulou M; Petraki K; Zografos K; Laoudi F; Sgouras D; Mentis A; Kasapidis P; Michopoulos S
    Eur J Intern Med; 2016 Jul; 32():84-90. PubMed ID: 27134145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.